SCHEMBL7967067

SCHEMBL7967067

COc1cc(C(=O)N(C)c2ccccc2N2CCCCC2)ccc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.55
MAPT P10636 8/20 0.55
NPSR1 Q6W5P4 3/20 0.55
LMNA P02545 5/20 0.51
ALOX12 P18054 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
MAPK1 P28482 4/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
HTT P42858 3/20 0.46
TP53 P04637 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
BCL2L2 Q92843 1/20 0.45
TDP1 Q9NUW8 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422011 0.91 SIRT6 (0.54) ALDH1A1MAPTNPSR1LMNAMAPK1
SCHEMBL7423456 0.90 ALDH1A1 (0.56) ALDH1A1MAPTLMNAALOX12MEN1
SCHEMBL7968869 0.83 KMT2A (0.49) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL7423134 0.82 PTPN1 (0.51) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL7423123 0.82 ALDH1A1 (0.55) ALDH1A1MAPTNPSR1LMNAALOX12
SCHEMBL7371553 0.82 ALDH1A1 (0.46) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL7418271 0.82 KMT2A (0.47) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL7371278 0.81 ALDH1A1 (0.44) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL7427932 0.79 ALDH1A1 (0.85) ALDH1A1MAPTNPSR1LMNAALOX12
SCHEMBL7426296 0.78 MAPT (0.49) ALDH1A1MAPTNPSR1LMNAALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed